2018 · 2017 · 2016 · 2015 · 2014 · 2013 ·
  • On October 8, Geistlich Pharma AG celebrated the opening of their tenth subsidiary, in India. The business was officially launched in the presence of the Swiss ambassador, Dr Andreas Baum, and marks Geistlich’s advance into a potentially very interesting market for the global leader in regenerative dentistry (Geistlich Biomaterials).

  • In future Geistlich Group websites will make a good impression on many different end devices. The responsive design in the background adjusts to any device.

  • Geistlich Pharma has captured its company history in a movie. Result: 165 years Geistlich in seven minutes. The film is available on the developed youtube channel of Geistlich Pharma.

  • Collagen plays an important role in the regeneration of tissues. This is why, over the years, Geistlich Pharma has become a specialist in collagen. A team of scientists at Geistlich Pharma works exclusively on collagen research. Vision: at some point, to extend medical regeneration to other parts of the human body.

  • Geistlich Pharma AG can look back on another successful financial year, enjoying mid single-digit growth in local currency sales, helped once again by the Dental division and its world-leading products. Geistlich Pharma also performed well in the Asia Pacific region and North America.

  • The close collaboration with scientists, customers and patients is a key element of product development at Geistlich Pharma. In the last 50 years, this approach has resulted in innovative products and therapeutic applications in the field of regenerative medicine.

  • Regenerative medicine for a better quality of life – that’s the focus of Geistlich Pharma’s research and development work. This is reflected in the company’s annual donation to charity, which in 2015 is for «Mercy Ships» Switzerland.

  • Geistlich Pharma gave a warm welcome to 14 boys and girls for National Future Day. The children, aged 10-13, gained insights into various departments in a pharmaceutical company.

  • The 1000th scientific study on Geistlich’s biomaterials in the field of regenerative dentistry was recently published in «PubMed». There are numerous scientists behind this figure who have contributed over several decades to the predictability and thus the safety of Geistlich Pharma’s products.

  • In future Geistlich Pharma will be relying more focused on the world’s biggest online professional network – LinkedIn – to recruit its medical regeneration specialists and executives. Here, in addition to current vacancies, potential candidates will be able to access interesting information about Geistlich Pharma as an employer.

Dr. Mirjam Kessler
Director Corporate Communications